Funds holding Tianjin Pharmaceutical Da Re Tang Group Corp. Ltd.
ISIN CNE100000924 · China · LEI 300300KHA32RYXJS8249
- Fund holders
- 4
- Of which ETFs
- 2 2 other funds
- Value held
- 113.8K $
This issuer has other securities: Tianjin Pharmaceutical Da Re Tang Group Corp Ltd (CNE000001808)
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| JNL Emerging Markets Index Fund JNL Series Trust | 19,500 | 53.9K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| JPMorgan BetaBuilders Emerging Markets Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 12,400 | 34.6K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| FlexShares Morningstar Emerging Markets Factor Tilt Index Fund FlexShares Trust | 4,900 | 13.7K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Franklin Emerging Market Core Dividend Tilt Index ETF Franklin Templeton ETF Trust | 4,200 | 11.6K $ | 0.02 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Franklin Emerging Market Core Dividend Tilt Index ETF Franklin Templeton ETF Trust | 0.02 % | as of Jun 30, 2026 ↗ |
| JPMorgan BetaBuilders Emerging Markets Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 0.00 % | as of Jul 31, 2026 ↗ |
| FlexShares Morningstar Emerging Markets Factor Tilt Index Fund FlexShares Trust | 0.00 % | as of Jul 31, 2026 ↗ |
| JNL Emerging Markets Index Fund JNL Series Trust | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 4 | +1 | 41,000 | +51.9 % |
| 2026Q2 | 3 | 0 | 27,000 | +3.1 % |
| 2026Q1 | 3 | 0 | 26,200 | +1.6 % |
| 2025Q4 | 3 | 0 | 25,800 | +3.2 % |
| 2025Q3 | 3 | 0 | 25,000 | -1.6 % |
| 2025Q2 | 3 | 0 | 25,400 | -1.9 % |
| 2025Q1 | 3 | +1 | 25,900 | -11.0 % |
| 2024Q4 | 2 | 0 | 29,100 | 0.0 % |
| 2024Q3 | 2 | 0 | 29,100 | 0.0 % |
| 2024Q2 | 2 | +1 | 29,100 | +49.2 % |
| 2024Q1 | 1 | -1 | 19,500 | -33.0 % |
| 2023Q4 | 2 | 29,100 |
Cite this page
Titelia. "Funds holding Tianjin Pharmaceutical Da Re Tang Group Corp. Ltd.". https://titelia.com/en/stocks/tianjin-pharmaceutical-da-re-tang-group-corp-ltd-CNE100000924